Ways2Well tells you exactly where it can treat you — a specific state count, and the four states it cannot serve. Then it tells you nothing at all about what you would receive or what it costs. It is an unusual combination, and the second half is the problem.
Peptides, Not GLP-1s
Ways2Well offers clinician-guided peptide therapy for recovery, metabolic health, performance and healthy ageing. No GLP-1 medication is named, and semaglutide and tirzepatide do not appear. If a GLP-1 is what you want, our provider rankings cover it.
The clinical sequence it describes is sound: a provider reviews your labs before anything is prescribed, and dosing and duration are set against the goal you came in with. That is better than the large part of the telehealth market that prescribes from a questionnaire and measures nothing. It also runs physical locations in Austin and Houston, so in-person care exists.
The category caveat from our Meto review applies equally here: peptide therapy for these indications carries a much weaker evidence base than the GLP-1 medications people usually arrive searching for, and marketing in this space consistently runs ahead of the trials.
The Coverage Disclosure Is Good
Ways2Well states care is available in 46 states, and identifies New York, New Jersey, Rhode Island and Missouri as the exclusions.
Naming the states you cannot serve is unusually useful, and rare. Across this category we have found “across the U.S.”, “multiple states” and “six states” without a list — none of which answers the only question that matters, which is whether you personally can be treated.
Telehealth prescribing is licensed state by state, so a four-state exclusion list is a concrete, checkable fact. It is the single best piece of disclosure on the site.
The Commercial Side Is Blank
Against that precision, almost nothing else is published. No pricing for peptide therapy, membership or lab testing. No peptide or medication named. No statement of whether preparations are compounded. No pharmacy, no shipping terms, no refund policy, no insurance or HSA/FSA position, and no eligibility criteria.
That combination is strange. Coverage is genuinely harder to state than price — it depends on clinician licensure in every state — and Ways2Well has done the hard one and skipped the easy one. The practical effect is that you can establish you are eligible to be treated and still have no idea what you would be taking or what it would cost until you engage.
Lab testing is described as part of the model, which makes the absent lab pricing more significant than it would be elsewhere — as we found at Marek Health, an unpriced lab requirement can turn into a substantial charge.
Provider Facts
| Medications offered | Clinician-guided peptide therapy for recovery, metabolic health, performance and healthy ageing; no peptides or GLP-1 medications named |
|---|---|
| Brand-name or compounded | Not stated - the site does not say whether preparations are compounded or brand-name |
| Consultation process | Not published; a provider reviews your labs before anything is prescribed |
| Eligibility | Not published - no BMI threshold stated |
| Provider involvement | A provider reads your labs before prescribing, with dosing and duration set to your stated goal |
| Lab requirements | Described as central to the model - a provider reviews them before prescribing; panels and cost not published |
| Pharmacy fulfillment | Not published |
| Shipping frequency | Not published |
| Support services | Telehealth plus in-person care at Austin and Houston locations |
| Membership fees | Not published |
| Medication fees | Not published |
| Cancellation policy | Not published |
| Refund policy | Not published |
| Insurance | Not published |
| HSA/FSA | Not published |
| Availability | Stated as 46 states, excluding New York, New Jersey, Rhode Island and Missouri; physical locations in Austin and Houston, Texas |
Pros and Cons
Pros
- States a specific state count and names the four exclusions
- Labs read by a provider before anything is prescribed
- Physical locations in Austin and Houston alongside telehealth
- Dosing described as set to the goal rather than a fixed protocol
- Makes no weight-loss claims it cannot support
Cons
- No pricing published for anything, including the labs the model depends on
- No peptide or medication named
- Not a GLP-1 provider despite surfacing in GLP-1 searches
- Compounded or brand-name status never addressed
- No pharmacy, shipping, refund, insurance or HSA/FSA detail
- Peptide therapy carries a much weaker evidence base than GLP-1 medication
Who It May Be Best For
Not a fit if you want a GLP-1. Ways2Well does not offer semaglutide or tirzepatide.
Possibly worth a call if you are in Austin or Houston, want lab-led preventive care with in-person access, and are specifically interested in peptide therapy on its own terms.
Ask for the whole price list before engaging — labs, membership and treatment — plus which peptides are involved and whether they are compounded. None of it is published, and all of it is answerable.
Alternatives
Meto is the closest peptide comparison and publishes every price. PRIME Medical Group offers lab-led care with real GLP-1s from $149 including bloodwork. Our providers with labs included page covers that segment.
Limitations of This Review
Based on Ways2Well’s own published materials at ways2well.com, checked on 6 September 2026. The excluded-states list was noted on a waitlist element rather than a formal coverage page, so confirm directly. Anything marked not published means we could not find it, and pricing is very likely given at consultation. Our comments on the peptide evidence base describe the category generally. Nothing here is medical advice.
Frequently Asked Questions
Does Ways2Well prescribe GLP-1 medication?
Not that it publishes. Its offering is clinician-guided peptide therapy, and neither semaglutide nor tirzepatide is named anywhere we looked.
Which states are excluded?
It states care in 46 states, with New York, New Jersey, Rhode Island and Missouri identified as exclusions — a more useful disclosure than most of this category offers.
What does it cost?
Not published — not treatment, membership or labs. Since lab testing is central to the model, ask for that price specifically.
Can I be seen in person?
Yes, at Austin and Houston locations, alongside telehealth across its stated footprint.
Verdict
2.7 / 5 — no pricing published; 46 states
The best coverage disclosure we have seen paired with the emptiest commercial one. A sound clinical sequence and real in-person access, undermined by publishing no price, no molecule and no terms.
The point worth carrying beyond this provider: disclosure is not one quality. A company can be scrupulous about the hard fact — which states it is licensed in — and silent on the easy one. Judge each disclosure separately rather than treating any single act of transparency as a signal about the rest.
Medical Disclaimer & Review Date
This review is general consumer information, not medical advice. GLP-1 medications are prescription drugs with serious contraindications, and whether any treatment is appropriate for you is a decision only a licensed healthcare provider who knows your medical history can make. Nothing here should be used to start, stop, or change a medication.
Details in this review come from Ways2Well's own published materials as of the date below. Pricing, medication availability, state coverage, and policies in this category change frequently — verify current terms directly with the provider before purchasing.
Date reviewed: September 6, 2026